Related Experiment Video
Updated: May 17, 2026
07:02
Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
Published on: September 9, 2020
Extended myectomy for hypertrophic obstructive cardiomyopathy.
Changqing Gao1, Chonglei Ren, Cangsong Xiao
1Department of Cardiovascular Surgery, General Hospital of PLA, Institute of Cardiac Surgery of PLA, Beijing, China. gaochq301@yahoo.com
The Heart Surgery Forum
|October 25, 2012
Summary
Extended ventricular septal myectomy effectively treats hypertrophic obstructive cardiomyopathy (HOCM) by significantly reducing left ventricular outflow tract obstruction and improving patient symptoms. Thorough septal excision is key to successful surgical outcomes.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Devices
Background:
- Hypertrophic obstructive cardiomyopathy (HOCM) is characterized by left ventricular hypertrophy and outflow tract obstruction.
- Systolic anterior motion (SAM) of the mitral valve and mitral regurgitation are common complications in HOCM patients.
Purpose of the Study:
- To summarize the surgical experience with extended ventricular septal myectomy in patients diagnosed with HOCM.
- To evaluate the efficacy and safety of this surgical approach for HOCM treatment.
Main Methods:
- Thirty-eight HOCM patients underwent extended ventricular septal myectomy.
- Preoperative and postoperative echocardiography (transesophageal and transthoracic) assessed systolic gradients and septal thickness.
- Intraoperative and follow-up assessments evaluated surgical outcomes, including SAM and mitral regurgitation.
Main Results:
- Extended ventricular septal myectomy significantly reduced mean systolic gradients from 94.8 mm Hg to 13.6 mm Hg (P=.0000).
- Ventricular septal thickness decreased from 28.3 mm to 11.8 mm (P=.0000), with significant reduction or elimination of SAM and mitral regurgitation.
- All patients experienced symptom resolution or improvement, with abolished syncope and reduced dyspnea.
Conclusions:
- Extended ventricular septal myectomy is a highly effective treatment for HOCM.
- Achieving adequate surgical exposure and performing thorough excision of the hypertrophic septum are critical for successful outcomes.
Related Concept Videos
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...